$EMHTF News
Last published 4y ago
- 4y agoEMHTFSKYESkye Bioscience Reports that Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement with SkyeGlobeNewswireSan Diego, California, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB:SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the shareholders
- 4y agoEMHTFSKYESkye Bioscience Signs Arrangement Agreement with Emerald Health TherapeuticsGlobeNewswireArrangement is expected to fund Skye's proprietary synthetic cannabinoid-derivative therapeutic initially targeting glaucoma for first Phase 2 clinical study planned to start later in 2022 Preclinical studies have demonstrated potential advantages o
- 5y agoABSSFABXXFADDYYAKCCF+44OTC Markets Group Announces Quarterly Index Performance and RebalancingPR NewswireNEW YORK, July 20, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX:OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced the second quarter 2021 performance and quarterly rebalancing of the OTCQX® and OTCQB® in
- 5y agoEMHTFEmerald Health Therapeutics, Inc. to Host Earnings CallACCESS NewswireNEW YORK, NY / ACCESSWIRE / May 3, 2021 / Emerald Health Therapeutics, Inc. (OTC:EMHTF) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on May 3, 2021 at 10:30 AM Eastern Time. To listen to the event live